关注
Robert Pearlstein
Robert Pearlstein
Senior Principal Scientist, Novartis Institutes for BioMedical Research
在 novartis.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies
R Farid, T Day, RA Friesner, RA Pearlstein
Bioorganic & medicinal chemistry 14 (9), 3160-3173, 2006
4942006
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches
RA Pearlstein, RJ Vaz, J Kang, XL Chen, M Preobrazhenskaya, ...
Bioorganic & medicinal chemistry letters 13 (10), 1829-1835, 2003
2982003
Understanding the Structure−Activity Relationship of the Human Ether-a-go-go-Related Gene Cardiac K+ Channel. A Model for Bad Behavior
R Pearlstein, R Vaz, D Rampe
Journal of Medicinal Chemistry 46 (11), 2017-2022, 2003
2082003
Structure–kinetic relationships of passive membrane permeation from multiscale modeling
CJ Dickson, V Hornak, RA Pearlstein, JS Duca
Journal of the American Chemical Society 139 (1), 442-452, 2017
1152017
New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factorlike repeat A docking site using WaterMap
RA Pearlstein, QY Hu, J Zhou, D Yowe, J Levell, B Dale, VK Kaushik, ...
Proteins: Structure, Function, and Bioinformatics 78 (12), 2571-2586, 2010
902010
A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations.
Z Lin, A Shenker, R Pearlstein
Protein engineering 10 (5), 501-510, 1997
841997
Contributions of water transfer energy to proteinligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors
RA Pearlstein, W Sherman, R Abel
Proteins: Structure, Function, and Bioinformatics 81 (9), 1509-1526, 2013
692013
The translocation kinetics of antibiotics through porin OmpC: insights from structurebased solvation mapping using WaterMap
QT Tran, S Williams, R Farid, G Erdemli, R Pearlstein
Proteins: Structure, Function, and Bioinformatics 81 (2), 291-299, 2013
602013
Molecular modeling studies of aldose reductase inhibitors
YS Lee, R Pearlstein, PF Kador
Journal of medicinal chemistry 37 (6), 787-792, 1994
441994
Comparative molecular field analysis of selective A3 adenosine receptor agonists
SM Siddiqi, RA Pearlstein, LH Sanders, KA Jacobson
Bioorganic & medicinal chemistry 3 (10), 1331-1343, 1995
381995
Estimation of solvation entropy and enthalpy via analysis of water oxygen–hydrogen correlations
C Velez-Vega, DJJ McKay, T Kurtzman, V Aravamuthan, RA Pearlstein, ...
Journal of chemical theory and computation 11 (11), 5090-5102, 2015
362015
Time-averaged distributions of solute and solvent motions: exploring proton wires of GFP and PfM2DH
C Velez-Vega, DJJ McKay, V Aravamuthan, R Pearlstein, JS Duca
Journal of chemical information and modeling 54 (12), 3344-3361, 2014
322014
Contributions of the membrane dipole potential to the function of voltage-gated cation channels and modulation by small molecule potentiators
RA Pearlstein, CJ Dickson, V Hornak
Biochimica et biophysica acta (BBA)-Biomembranes 1859 (2), 177-194, 2017
312017
Structurekinetic relationship of carbapenem antibacterials permeating through E. coli OmpC porin
QT Tran, RA Pearlstein, S Williams, J Reilly, T Krucker, G Erdemli
Proteins: Structure, Function, and Bioinformatics 82 (11), 2998-3012, 2014
312014
Uncoupling the structure–activity relationships of β2 adrenergic receptor ligands from membrane binding
CJ Dickson, V Hornak, C Velez-Vega, DJJ McKay, J Reilly, DA Sandham, ...
Journal of medicinal chemistry 59 (12), 5780-5789, 2016
302016
Implications of dynamic occupancy, binding kinetics, and channel gating kinetics for hERG blocker safety assessment and mitigation
R A Pearlstein, K Andrew MacCannell, G Erdemli, S Yeola, G Helmlinger, ...
Current Topics in Medicinal Chemistry 16 (16), 1792-1818, 2016
262016
On how a myosin tryptophan may be perturbed.
DB Bivin, S Kubota, R Pearlstein, MF Morales
Proceedings of the National Academy of Sciences 90 (14), 6791-6795, 1993
231993
Probing the dynamic structure-function and structure-free energy relationships of the corona virus main protease with Biodynamics theory
H Wan, V Aravamuthan, RA Pearlstein
bioRxiv, 2020
202020
Biodynamics: A novel quasi-first principles theory on the fundamental mechanisms of cellular function/dysfunction and the pharmacological modulation thereof
G Selvaggio, RA Pearlstein
PLoS One 13 (11), e0202376, 2018
152018
Building new bridges between in vitro and in vivo in early drug discovery: Where molecular modeling meets systems biology
RA Pearlstein, DJJ McKay, V Hornak, C Dickson, A Golosov, T Harrison, ...
Current Topics in Medicinal Chemistry 17 (23), 2642-2662, 2017
152017
系统目前无法执行此操作,请稍后再试。
文章 1–20